Commentary Open Access
Volume 3 | Issue 3 | DOI: https://doi.org/10.33696/diabetes.3.044
Commentary on Once-Weekly Semaglutide in Adults with Overweight or Obesity
Erica M. Garner1, Kevin D. Niswender1, Gitanjali Srivastava1,2,3,*
- 1Division of Diabetes, Endocrinology & Metabolism, Department of Medicine, Vanderbilt University School of Medicine, Nashville,TN, USA
- 2Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN, USA
- 3Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA
Corresponding Author
Gitanjali Srivastava, gitanjali.srivastava@vumc.org
Received Date: August 19, 2021
Accepted Date: August 24, 2021
Garner EM, Niswender KD, Srivastava G. Commentary on Once-Weekly Semaglutide in Adults with Overweight or Obesity. J Diabetes Clin Res. 2021; 3(3):81-84.
Copyright: © 2021 Garner EM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
GLP-1R agonist, Semaglutide, Overweight, Obesity, Weight loss, Diabetes, Anti-obesity medication
Recommended Articles
Platelet Hyperactivity and Dysfunction in Diabetes and Cancer
However, the entire coagulation cascade is dysfunctional, in progressed chronic diabetes and cancer patients. Platelets (PLTs) in type 2 diabetic (DT2) involved in Thrombosis and Haemostasis (T&H) of individuals adhere to vascular endothelium and aggregate more voluntarily than those in healthy individuals, as are abnormalities in the microvascular and macrovascular circulations. However it is already known that the circulating PLTs are essential for T&H, inflammation growth factors delivery, regeneration; and knowledge of their function is fundamental to understanding the pathophysiology of vascular disease in diabetes and cancer-related diseases.
How Traditional Healers Diagnose and Treat Diabetes Mellitus in the Pretoria Mamelodi Area and How Do These Purported Medications Comply with Complementary and Alternative Medicine Regulations
In South Africa, new amended regulations required a review of complementary and alternative medicine (CAMs) call-up for registration from November 2013. This impacted traditional healers (THs)’ compliance with the regulatory authorities’ on the good manufacturing practice which in return affected the public’s access to CAMs. This investigation embraces methods, THs use to diagnose and treat diabetes (DM) in Mamelodi. Furthermore, it assesses what their purported medications comprise of.
Energy Expenditure and Nutrition in Neurogenic Obesity following Spinal Cord Injury
Worldwide, obesity is a public health concern and a metabolic ailment characterized by excessive adipose tissue accumulation resulting from an imbalance of energy expenditure and energy intake [1]. This disorder is a known risk factor for cardiovascular disease, type 2 diabetes mellitus, dyslipidemia, hypertension, and metabolic
Improving Obesity and Insulin Resistance by Targeting Skeletal Muscle MKP-1
Obesity has reached a global epidemic and it predisposes to the development of insulin resistance, type 2 diabetes and related metabolic diseases. Current interventions against obesity and/or type 2 diabetes such as calorie restriction, exercise, genetic manipulations or established pharmacological treatments have not been successful for many patients with obesity and/or type 2 diabetes.
Integrated Community Diabetes Model: Future of Diabetes Services and Way Forward?
Prevalence of diabetes is increasing. Diabetes is more prevalent in the socially deprived, ethnic minority population (based on continuing rise in elderly population, growing obesity and BME groups). Compliance is a major stumbling block in the management of most long-term conditions including diabetes.